BioCentury
ARTICLE | Company News

Graffinity, NovAliX deal

November 22, 2010 8:00 AM UTC

NovAliX acquired a majority stake in fragment-based drug discovery services company Graffinity. NovAliX said Graffinity's small molecule library and SPR-imaging technology will complement NovAliX's x-...